Susquehanna International Group, LLP Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $5.46 $6,204 - $307,944	-56,400 Reduced 52.47%	51,100 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $5.31 $7,140 - $223,019	-42,000 Reduced 28.09%	107,500 $18,000
Q2 2022 Aug 15, 2022	BUY	$0.21 - $0.53 $6,867 - $17,331	32,700 Added 28.0%	149,500 $37,000
Q1 2022 May 16, 2022	BUY	$0.32 - $0.67 $26,016 - $54,471	81,300 Added 229.01%	116,800 $62,000
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.11 $79,080 - $146,298	-131,800 Reduced 78.78%	35,500 $22,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $111,706 - $201,292	-110,600 Reduced 39.8%	167,300 $171,000
Q2 2021 Aug 11, 2021	SELL	$1.39 - $2.21 $41,700 - $66,300	-30,000 Reduced 9.74%	277,900 $509,000
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $106,680 - $287,280	84,000 Added 37.52%	307,900 $607,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $1.02 Million - $2.05 Million	-1,087,300 Reduced 82.92%	223,900 $280,000
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $672,900 - $4.21 Million	448,600 Added 52.01%	1,311,200 $2.36 Million
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $1.93 Million - $3.38 Million	402,500 Added 87.48%	862,600 $7.24 Million
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $1.52 Million - $3.19 Million	442,800 Added 2559.54%	460,100 $2.41 Million
Q4 2019 Feb 14, 2020	SELL	$4.29 - $5.64 $398,970 - $524,520	-93,000 Reduced 84.32%	17,300 $94,000
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $67,206 - $97,704	-13,800 Reduced 11.12%	110,300 $537,000
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $1.06 Million - $1.26 Million	-161,100 Reduced 56.49%	124,100 $860,000
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $1.41 Million - $2.2 Million	245,500 Added 618.39%	285,200 $1.98 Million
Q4 2018 Feb 14, 2019	SELL	$5.26 - $7.97 $772,694 - $1.17 Million	-146,900 Reduced 78.72%	39,700 $232,000
Q3 2018 Nov 14, 2018	BUY	$4.65 - $7.95 $676,110 - $1.16 Million	145,400 Added 352.91%	186,600 $1.41 Million
Q2 2018 Aug 14, 2018	BUY	$5.05 - $6.8 $59,085 - $79,560	11,700 Added 39.66%	41,200 $208,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $169,625 - $228,625	29,500	29,500 $211,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$329,249
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$25,890
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$22,588
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account